Published on: 21 April 2017
Canadian health and wellness company PreveCeutical Medical Inc. (PMI) has signed a research and option agreement with UniQuest, The University of Queensland’s main commercialisation company, to develop stabilised natural and synthetic peptides from scorpion venom for immune-boosting applications.